Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc > AGN is VERY Promising right now

<< Previous

Bullboard Posts

Next >>

Post by DigitalSpurson May 29, 2020 3:58pm

131 Views

Post# 31089668

AGN is VERY Promising right now

Bloomberg call on them earlier today
Drug is safe and has been around for a few decades
Tests show its promise and company has a 20X less market cap competitor in Bellus Health

Even if it's a quarter of the size, we are looking at a five fold increase from current price levels - I definitely see this running VERY quickly

IMO there will be a halt on Monday morning for some incredible news on the call scheduled

Over 40 cents next week is my guess!

<< Previous

Bullboard Posts

Next >>

Four of the Magnificent Seven dropped today: Here's why